InVivo co-founder receives 2011 The Economist annual Innovation Award in Bioscience

InVivo Therapeutics Holdings Corp. (OTC/BB: NVIV), a company focused on the development of groundbreaking technologies for the treatment of spinal cord injuries (SCI), today congratulates Robert S. Langer, Sc.D., InVivo co-founder and member of the Company's Scientific Advisory Board, for his selection as the recipient of the 2011 The Economist annual Innovation Award in Bioscience.

The Economist was established in 1843 and is now recognized as one of the most important contributors to economic growth. The annual Economist Innovation Awards recognizes talented people presented in eight fields: bioscience, computing and telecommunications, energy and the environment, social and economic innovation, business-process innovation, consumer products, a flexible "no boundaries" category, and the corporate use of innovation.

Dr. Langer was awarded in the Bioscience category for his pioneering work on controlled-release drug delivery and tissue engineering, which has benefited tens of millions of people.

Dr. Langer is the most cited engineer in history, having written nearly 1,130 articles and holding more than 800 issued or pending patents. Dr. Langer's research has resulted in a suite of patents for InVivo, a company dedicated to the development of groundbreaking technologies for the treatment of spinal cord injuries.